{
  "docId": "019de074-2973-7208-9395-338d3116556a",
  "docSlug": "4059563425860536cb0bf09c6eb6bba5",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 29 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 29,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "key_takeaways",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 5,
  "notes": "The slide is split into two main sections: a case study on baricitinib (left) and a partnership overview with DNDi (right).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2973-7208-9395-338d3116556a/26",
  "deckHref": "/decks/019de074-2973-7208-9395-338d3116556a",
  "deckJsonHref": "/decks/019de074-2973-7208-9395-338d3116556a.json",
  "deckAnchorHref": "/decks/019de074-2973-7208-9395-338d3116556a#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.65,
        "y": 0.05
      },
      "kind": "image",
      "text": "DNDi Drugs for Neglected Diseases initiative",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "700f39d9-f764-4a05-af60-78b9e073860b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.35,
        "y": 0.75
      },
      "kind": "image",
      "text": "Lilly",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6b89cb8-1c7e-48f3-9d24-37ba3ba3c5fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "image",
      "text": "FDA",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f34930d9-782c-4289-8476-0fdbd1e0c68e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.65,
        "y": 0.35
      },
      "kind": "list",
      "text": "Focused on Dengue fever - a major healthcare burden; Aims to deliver biological targets and drug repurposing candidates; Experimental validation in progress - 6 assays",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e17738e-7baf-43a5-96e9-28d8bd23faa3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.55,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "RAPID: Identified baricitinib as a treatment in just 48 hours, published research in The Lancet in Feb 2020",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9a11032-fa3e-46eb-bdc8-0533d8ea1094",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.55,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "NOVEL: Our technology and AI workflows identified a previously unknown antiviral mechanism",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aafa5f5c-5ac3-4231-8eea-2b2417955e79",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.55,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "list",
      "text": "EFFECTIVE: COV-BARRIER trial showed baricitinib reduces mortality by 38% in hospitalised patients, and by 46% in ventilated or ECMO patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0284059-bc43-4c9f-a2e9-5fd89302b5cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "FDA approved the baricitinib to treat COVID-19 in May 2022 after first granting EUA in Nov 2020",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06b4fbb9-23df-4da5-a840-35c03c190c27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.25,
        "x": 0.35,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Led to equity investment from Eli Lilly",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c052c51-8376-4838-b671-a6ee1607a597",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.55,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Identified a COVID-19 treatment now approved for use by the FDA",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa07a0e3-874e-45ee-86f2-4ed0aa7829b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Using our platform for wider societal benefit",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "847b56f3-e0cd-4edd-b4c7-fe68071890e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.65,
        "y": 0.2
      },
      "kind": "title",
      "text": "Non-commercial collaboration",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e44172f7-d18e-48f9-89c9-f766db4404d6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "506ee05c-916a-4fec-b83e-eafd740d3045",
      "evidence": "The slide contains a list of bullet points.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 29,
      "from": 16,
      "beatId": "3b0e5288-2029-43c9-ada8-d64afac944d7",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "The call to action is clear, with a roadmap and ask for investors",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}